Electronic Nudge Letters Fail to Boost Guideline-Adherent Treatment in CKD Patients
A recent study finds that electronic nudge letters do not increase guideline-based medical therapy uptake among CKD patients, highlighting challenges in digital health interventions.
Recent research has shown that sending electronic nudge letters to patients with chronic kidney disease (CKD) or their healthcare providers does not significantly increase the adoption of guideline-recommended medical therapies. A large nationwide study, published in the journal Circulation on June 7, 2025, evaluated whether these digital prompts could improve treatment rates. The trial included over 23,000 patients with CKD and involved randomizing them to receive either an electronic nudge letter or usual care, along with their general practices being similarly assigned to receive informational letters or not.
The primary medications targeted were renin-angiotensin system inhibitors (RASi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i), known for their benefits in CKD management. The results demonstrated that approximately 65% of patients, regardless of whether they received a nudge, filled prescriptions for these medications during the follow-up period. Similarly, no significant difference was observed in prescription rates among practices that received electronic informational letters versus those that did not. In essence, neither the patient-directed nor the provider-directed electronic interventions led to improved guideline-adherent medication use.
The researchers concluded that large-scale digital nudges, at least as implemented in this trial, do not enhance the adoption of recommended therapies in CKD management. This finding underscores the challenge of effecting behavioral change through electronic prompts and provides valuable insights for future efforts to improve medical guideline adherence. The study emphasizes the importance of exploring alternative strategies to increase the implementation of proven treatments for CKD.
For more details, see the full study in Circulation: DOI: 10.1161/CIRCULATIONAHA.125.075403. Source: https://medicalxpress.com/news/2025-06-electronic-nudge-letters-guideline-medical.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Dual-Target CAR T Cell Therapy Shows Promise Against Aggressive Brain Cancer
A groundbreaking dual-target CAR T cell therapy shows promise in reducing tumor growth in patients with life-threatening glioblastoma, offering new hope for treatment-resistant brain cancer.
New Discoveries in Ovarian Cancer: The Role of Whole-Genome Doubling in Treatment Development
Recent studies reveal that whole-genome doubling plays a key role in ovarian cancer progression and immune suppression, paving the way for innovative treatment strategies. Learn how understanding this process could improve outcomes for patients with high-grade serous ovarian carcinoma.
Potential Risks of Routine AI Assistance on Endoscopist Skills in Colonoscopy
A new study warns that routine AI assistance in colonoscopy may reduce endoscopists' ability to detect adenomas, raising concerns about long-term clinician skills and patient outcomes.
Balancing Benefits and Risks of Lung Cancer Screening: What You Need to Know
Lung cancer screening can save lives through early detection, but it also carries risks like overdiagnosis, unnecessary procedures, and incidental findings. Learn about the benefits and potential harms of screening programs.